Zobrazeno 1 - 10
of 19
pro vyhledávání: '"José C. Jaime-Pérez"'
Autor:
José C. Jaime-Pérez, Ernesto Picón-Galindo, César H. Gutiérrez-Aguirre, Olga G. Cantú-Rodríguez, Andrés Gómez-De León, Perla R. Colunga-Pedraza, Luz Tarín-Arzaga, Dalila M. Alvarado Navarro, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 26, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/14594bafbca24d239fd74d000a7b6a7e
Autor:
José C. Jaime-Pérez, María L. Ruiz-De la Cruz, Sandra I. Mendoza-Ibarra, Nidia K. Moncada-Saucedo, David Gomez-Almaguer
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 5 (2023)
Background: Recipients of a related haploidentical stem cell transplant (haplo-SCT) can have preformed antibodies to HLA donor’s antigens. Objective: The aim of the study was to evaluate the engraftment rate and major clinical associations of anti-
Externí odkaz:
https://doaj.org/article/b6b0172fd4654311b44f138833138774
Autor:
Andrés Gómez-De León, Perla R. Colunga-Pedraza, Luz Tarín-Arzaga, Emmanuel Bugarín-Estrada, Lilian Sung, Omar Cantú-Martínez, José C. Jaime-Pérez, David Gómez-Almaguer
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 622-631 (2021)
PURPOSE:Establishing research capacity in low- and middle-income countries (LMICs) is key for improving the outcomes of patients with hematologic diseases globally. Few studies have analyzed the contributions of LMICs to global hematology. The Americ
Externí odkaz:
https://doaj.org/article/58cb81e26ef04815b8e7d3001ef918fe
Autor:
José C. Jaime-Pérez, Carlos de la Cruz-de la Cruz, Luz Tarín-Arzaga, Luis A. González-Torres, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 24, Iss 4 (2022)
Background: Multiple myeloma (MM) is an infrequent hematologic entity in patients 40 years or younger, with a clinical presentation and disease course that differs from the older group. We report the clinical outcomes after diagnosing and treating yo
Externí odkaz:
https://doaj.org/article/e0449a84579d49f0ac564c75bed2f71c
Autor:
José C. Jaime-Pérez
Publikováno v:
Medicina Universitaria, Vol 24, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/a12dfc20cddf4ce9b1715ced523bc18e
Autor:
Luz Tarín-Arzaga, Omar Cantu-Martinez, Carlos de la Cruz-de la Cruz, Odra L. Martínez-González, Martha A. Reyes-López, José C. Jaime-Pérez, David Gómez-Almaguer
Publikováno v:
Medicina Universitaria, Vol 24, Iss 2 (2022)
Background: Serum protein electrophoresis (SPE), immunofixation, and free light chain assays are recommended for monoclonal gammopathy (MG) screening. High serum globulins might be an inexpensive and useful parameter to decide on a workup for MG. Obj
Externí odkaz:
https://doaj.org/article/f6f3261ac16c4466b843671ff186bcaf
Autor:
José C. Jaime-Pérez, César D. Villarreal-Villarreal, Eduardo Vázquez-Garza, Nereida Méndez-Ramírez, Rosario Salazar-Riojas, David Gómez-Almaguer
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 1151-1155 (2016)
This article provides flow cytometry information regarding levels of expression for hematopoietic stem cell markers CD34 and CD133 obtained simultaneously of the bone marrow and peripheral blood from recipients of allogeneic and autologous transplant
Externí odkaz:
https://doaj.org/article/7d1db0db7c3545a6aac56422efd75c52
Autor:
Gabriela Galindo-Rodríguez, José C. Jaime-Pérez, Mario C. Salinas-Carmona, Sandra N. González-Díaz, Ángeles Castro-Corona, Raúl Cavazos-González, Humberto Treviño-Villarreal, Alberto C. Heredia-Salazar, David Gómez-Almaguer
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 3, Pp 202-209
Abstract Background l-Asparaginase is essential in the treatment of childhood acute lymphoblastic leukemia. If immunoglobulin G anti-l-asparaginase antibodies develop, they can lead to faster plasma clearance and reduced efficiency as well as to hype
Externí odkaz:
https://doaj.org/article/8af78704273045bd950115ad4b1c2769
Autor:
David Gómez-Almaguer, Edgar A. Rojas-Guerrero, Andrés Gómez-De León, Perla R. Colunga-Pedraza, José C. Jaime-Pérez
Publikováno v:
Expert review of hematology. 15(6)
Primary immune thrombocytopenia (ITP) is an acquired bleeding disorder. Conventionally, first-line ITP therapy aims to obtain a rapid response and stop or decrease the risk of bleeding by increasing the platelet count. At this point, the duration of
Autor:
José C. Jaime-Pérez
Publikováno v:
Revista Medicina Universitaria. 20